Axonics

Axonics Debt / Assets

Debt-to-Assets Ratio of Axonics (AXNX) as of Nov 19, 2026.

Debt / Assets

0.00

Last updated:

Debt-to-Assets Ratio of Axonics is 2023 0.00 . Debt-to-Assets Ratio of Axonics was 2022 0.00 . It decreases by % lower compared to the previous year.

The Axonics Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2016
0.03 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.14 USD
Jan 1, 2019
0.09 USD
Jan 1, 2020
0.06 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
The Axonics Debt / Assets history
YEARDebt / AssetsYoY
0.00—
0.00—
0.00-100.00%
0.06-33.23%
0.09-32.45%
0.14+3,920.65%
0.00-87.70%
0.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Axonics since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Axonics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Axonics

All Key Metrics — Axonics